Promoter Hypermethylation of Tumor-Suppressor Genes <i>p16<sup>INK4a</sup>, RASSF1A, TIMP3</i>, and <i>PCQAP/MED15</i> in Salivary DNA as a Quadruple Biomarker Panel for Early Detection of Oral and Oropharyngeal Cancers
Silencing of tumor-suppressor genes (TSGs) by DNA promoter hypermethylation is an early event in carcinogenesis; hence, TSGs may serve as early tumor biomarkers. We determined the promoter methylation levels of <i>p16<sup>INK4a</sup></i>, <i>RASSF1A</i>, <i>...
Main Authors: | Chamikara Liyanage, Asanga Wathupola, Sanjayan Muraleetharan, Kanthi Perera, Chamindie Punyadeera, Preethi Udagama |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/4/148 |
Similar Items
-
<i>ANK2</i> Hypermethylation in Canine Mammary Tumors and Human Breast Cancer
by: Johannes J. Schabort, et al.
Published: (2020-11-01) -
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
by: Gang Xu, et al.
Published: (2020-11-01) -
Frequent Hypermethylation of RASSF1A, TSLC1, High Viral Load of Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma, Matched Tumor-Adjacent Tissues
by: Liang Zhou, et al.
Published: (2005-09-01) -
RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia
by: Liu F, et al.
Published: (2017-08-01) -
Assessment of Hypermethylation of RASSF1A and Protocadherin-10 Tumor Suppressor Genes in Breast Cancer Females: A Six-Year Disease-Free Survival Case-Control Study
by: Samia A. Ebeid, et al.
Published: (2016-01-01)